In this SlideShare, we explore the potentially game-changing diagnostic and monitoring method for cancer patients, known as Liquid Biopsy. A simple and non-invasive alternative to conventional surgical biopsies, liquid biopsy enables doctors to discover a range of information about a patient’s tumor through a simple blood sample. We will also cover on how Intervenn’s unique glycoproteomics & AI analysis platform is being developed to detect colorectal pre-cancer.